InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Galmed Pharmaceuticals Ltd.

GLMD Clue Score40
Israel Fiscal year ends December CIK 0001595353
Alert on the numbers Alert on insider trades

Key numbers

Fiscal year 2020, ended 31 Dec 2020, as filed
Revenue
$0.00
Net income
$28.77M
Free cash flow
$26.33M
Return on equity
-65.2%
Return on capital
-54.1%
Debt to equity
0.00

Revenue and profit

Fiscal years, as filed with the SEC · point at a year for the detail
Full statements →
0K -29M FY20 Fiscal year 2020 Revenue $0.00 Net income $28.77M Margin n/a 0K -32M FY21 Fiscal year 2021 Revenue $0.00 Net income $32.47M Margin n/a 0K -18M FY22 Fiscal year 2022 Revenue $0.00 Net income $17.87M Margin n/a 0K -7M FY23 Fiscal year 2023 Revenue $0.00 Net income $6.91M Margin n/a 0K -8M FY24 Fiscal year 2024 Revenue $0.00 Net income $7.52M Margin n/a 0K -10M FY25 Fiscal year 2025 Revenue $0.00 Net income $10.31M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →

No open-market purchase or sale on file for this company.